HPV DNA vaccine (PowderMed)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHPV DNA vaccine (PowderMed)
Drug Alias NameDNA vaccine (PowderJect)human papillomavirus vaccine (Powderject/GlaxoSmithKline)HPV DNA vaccine (Pfizer)HPV DNA vaccine (Powderject/GlaxoSmithKline)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPowderject Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPowderject PharmaceuticalsGlaxosmithkline PlcPowdermed Ltd
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A